4.3 Article

Cefiderocol MIC quality control ranges in iron-depleted cation-adjusted Mueller-Hinton broth using a CLSI M23-A4 multi-laboratory study design

期刊

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.diagmicrobio.2017.03.011

关键词

Cefiderocol; S-649266; Quality control; M23; Siderophore cephalosporin

资金

  1. Shionogi & Co., Ltd. (Osaka, Japan)
  2. Allergan
  3. Astellas
  4. Cubist Pfizer
  5. Cempra
  6. Theravance

向作者/读者索取更多资源

Cefiderocol (formerly S-649266) is a new catechol-substituted parenteral siderophore cephalosporin with potent in vitro antibacterial activity against Gram-negative isolates including multidrug-resistant strains. A recent study following CLSI M23-A4 quality control guidelines established cefiderocol MIC QC ranges against Escherichia coil ATCC 25922 (0.06-0.5 mu g/mL) and Pseudomonas aeruginosa ATCC 27853 (0.06-0.5 mu g/mL). (C) 2017 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据